Advertisement

Topics

| CPDA-1 [Fenwal, Inc.] | BioPortfolio

13:21 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Rx only

Integral Donor Tube (IDT).

Use aseptic technique.

Caution: Do not use unless anticoagulant is clear.

For further processing with multiple BLOOD-PACK units, use standard component processing techniques.

Definition of Symbols:

Manufacturer

Dispose of container appropriately.

Single use only.

Do not use if there is any visible sign of deterioration.

Do not vent.

Sterilized by steam. Sterile fluid path.

Non-pyrogenic fluid path.

Store at Controlled Room Temperature.USP Definition of “Controlled Room Temperature” United States Pharmacopeia, General Notices.United States Pharmacopeial Convention, Inc.12601 Twinbrook Parkway, Rockville, MD

Manufactured by: Fenwal, Inc. Lake Zurich, IL 60047 USA

Made in USA

Fenwal International, Inc. Road 357, Km. 0.8Maricao, PR 00606

Imported and distributed in India by: Fenwal India Pvt Ltd Upper Ground Floor, Tower BDLF Building No. 10, DLF Cyber CityDLF Phase-II, Gurgaon 122 002, Haryana, IndiaImport License No.: FF-504-14890

FENWAL and BLOOD-PACK are trademarks of Fenwal, Inc.

07-19-04-284 REV: A01/2010

© 2010 Fenwal, Inc. All rights reserved.

REF R4R7634

6 Units

Fenwal™

Triple BLOOD-PACKUnitAnticoagulant Citrate PhosphateDextrose Adenine Solution (CPDA-1)

PL 146 Plastic

Rx only

Triple BLOOD-PACKunit consisting of a primary pack containing 49 mL of CPDA-1 anticoagulant solution and two transfer packs without solution for collection of 350 mL of blood, 16 gauge needle.

See instructions for use. Sterile, non-pyrogenic fluid path. Steam sterilized. Single use only. Do not vent. Do not use if there is any visible evidence of deterioration. Dispose of container appropriately. Store at Controlled Room Temperature (refer to direction insert).

Unused packs in open foil pouch may be kept to 60 days by folding and securing open end of foil pouch, to prevent possible loss of moisture.

Direct handling of product surfaces prior to extended storage in the foil pack may result in mold growth.

Each 49 mL CPDA-1 solution contains 1.56 g Dextrose (monohydrate), USP, 1.29 g Sodium Citrate (dihydrate), USP, 160 mg Citric Acid (monohydrate), USP, 109 mg Monobasic Sodium Phosphate (monohydrate), USP, 13.5 mg Adenine, USP, Water for Injection USP to 49 mL.

Manufactured by: Fenwal International, Inc. oad 357, Km. 0.8aricao, PR 00606

Made In USA

Imported and distributed in Indonesia by: PT.Medquest Jaya Global Menara Salemba 6th Floor Jl.Salemba Raya Kav 5-5A Jakarta-Indonesia 10440 Reg. No.: See Instructions for use.

Imported and distributed in India by: Fenwal India Pvt Ltd Upper Ground Floor, Tower BDLF Building No. 10, DLF Cyber CityDLF Phase-II, Gurgaon 122 002, Haryana, IndiaImport License No.: FF-504-14890MRP: Rs. 239 (inclusive of all taxes)

FENWAL and BLOOD-PACK are trademarks of Fenwal, Inc.

PL 146 is a trademark of Baxter International, Inc.

07-28-04-287 REV: A

Manufacturer

Fenwal, Inc.

Active Ingredients

Source

Drugs and Medications [38 Associated Drugs and Medications listed on BioPortfolio]

Cpda-1 [fenwal, inc.]

Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) Blood-Pack Unit

Cpda-1 [fenwal, inc.]

Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) BLOOD-PACK™ Unit

Cpda-1 [fenwal, inc.]

Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) BLOOD-PACK™ Unit

Cpda-1 [fenwal, inc.]

Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) BLOOD-PACK™ Unit

Cpda-1 [fenwal, inc.]

Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) BLOOD-PACK™ Unit

Clinical Trials [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Computational comparative mechanistic study of C-E (E=C,N,O,S) couplings via CO2 activation mediated by uranium(III) complexes.

We report a DFT mechanistic study on the functionalization of CO2 to form C-C, C-N, C-S, and C-O bonds promoted by trivalent uranium complexes (Tp)2UR [Tp = hydrotris(3,5-dimethylpyrazolyl)-borate lig...

Synthesis, characterization and antibacterial activity of Zn(II) coordination polymer.

In this study, the zinc(II)-based coordination polymer, [Zn(CPDA)(NO))](CPDA = 1,2-cyclopentanedicarboxylic acid) (1), had been successfully synthesized according to the hydrothermal method. After...

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record